Healthcare Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 01/16/2026 | CALL | $1,300.00 | 4,393 | +3,230 | +277.73% |
| 01/16/2026 | CALL | $1,140.00 | 3,658 | +3,158 | +631.60% |
| 12/05/2025 | PUT | $1,030.00 | 1,142 | +1,014 | +792.19% |
| 06/18/2026 | CALL | $1,460.00 | 799 | +699 | +699.00% |
| 12/05/2025 | CALL | $1,170.00 | 581 | +557 | +2,320.83% |
| 12/05/2025 | PUT | $1,070.00 | 541 | +527 | +3,764.29% |
| 12/05/2025 | CALL | $1,100.00 | 389 | -263 | -40.34% |
| 11/28/2025 | CALL | $1,080.00 | 480 | -281 | -36.93% |
| 04/17/2026 | CALL | $1,240.00 | 296 | -286 | -49.14% |
| 01/16/2026 | CALL | $1,200.00 | 4,668 | -410 | -8.07% |
| 12/19/2025 | CALL | $1,100.00 | 2,171 | -482 | -18.17% |
| 01/16/2026 | CALL | $1,060.00 | 4,051 | -528 | -11.53% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.74% | 26M | 11.45B |
| Vanguard 500 Index Fund | 1.92% | 18.23M | 8.03B |
| Vanguard/Primecap Fund | 1.56% | 14.85M | 6.54B |
| Fidelity 500 Index Fund | 0.91% | 8.65M | 3.81B |
| SPDR S&P 500 ETF Trust | 0.90% | 8.54M | 3.76B |
| Vanguard Specialized-Health Care Fund | 0.80% | 7.64M | 3.37B |
| iShares Core S&P 500 ETF | 0.74% | 7.04M | 3.1B |
| Washington Mutual Investors Fund | 0.73% | 6.95M | 3.06B |
| Growth Fund Of America Inc | 0.71% | 6.7M | 2.95B |
| Select Sector SPDR Fund-Health Care | 0.67% | 6.41M | 2.82B |
HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting
11/26 08:00 pm
GlobeNewswire Inc.
Read moreStock Split Watch: Is Eli Lilly Next?
11/26 11:30 am
The Motley Fool
Read moreDid Pfizer Just Say "Checkmate" to Novo Nordisk?
11/26 05:15 am
The Motley Fool
Read moreAI Just Sparked Biotech's Biggest Rally Since 2004 — Why Isn't Anyone Talking About It?
11/25 04:14 pm
Benzinga
Read moreEli Lilly’s $1 Trillion Cap: How the Pharma Giant Shattered Healthcare’s Ceiling
11/25 11:20 am
Investing.com
Read moreWhy Is Biogen Stock Trading Higher After Semaglutide Alzheimer's Data?
11/24 12:17 pm
Benzinga
Read moreBillionaire Stanley Druckenmiller Dropped Nvidia, Palantir, and Eli Lilly Over the Past Year and Just Bought the 2 Cheapest Magnificent Seven Stocks.
11/23 08:10 pm
The Motley Fool
Read more2 Top Dividend Stocks for Growth-Oriented Investors
11/23 03:05 pm
The Motley Fool
Read moreNovo Nordisk Just Took a Big Swing, Slashing Its GLP-1 Drug Prices. Will It Pay Off for the Healthcare Giant?
11/23 05:30 am
The Motley Fool
Read more2 Major Stocks Want to Dominate the GLP-1 Market. Which One Looks Like the Leader Heading Into 2026?
11/22 07:13 pm
The Motley Fool
Read moreUS Equities Show Signs of Stabilizing While Yield Compression Supports Risk
11/21 02:37 pm
Investing.com
Read moreNovo Nordisk Will Soon Reveal Whether Its GLP-1 Drug Can Slow Alzheimer's
11/21 11:36 am
Benzinga
Read moreIs Pfizer's 6.9%-Yielding Dividend Still Safe?
11/20 10:30 am
The Motley Fool
Read moreHealthcare Rotation Underway: 3 Stocks Leading the Charge
11/19 10:37 am
Investing.com
Read moreIs Recursion Pharmaceuticals a Meme Stock?
11/19 09:13 am
The Motley Fool
Read moreMissed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
11/19 07:05 am
The Motley Fool
Read moreTech Stocks Drop, Pharma Gains As Sector Rotation Picks Up: What's Moving Markets Tuesday?
11/18 02:15 pm
Benzinga
Read moreNovo Nordisk Leans Into Affordability Amid Rising Competition
11/17 02:01 pm
Benzinga
Read moreLifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk
11/17 09:00 am
GlobeNewswire Inc.
Read moreThis Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000?
11/17 06:25 am
The Motley Fool
Read moreEli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare Giants' Stocks?
11/16 01:10 pm
The Motley Fool
Read moreMaplebear, Tower Semiconductor, And Eli Lilly Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 10-Nov. 14): Are the Others in Your Portfolio?
11/16 09:31 am
Benzinga
Read moreBitget incluye los futuros perpetuos sobre los índices bursátiles LLY, MA y UNH, mientras que el volumen acumulado de operaciones en Bitget alcanza los $3 mil millones
11/14 01:54 am
GlobeNewswire Inc.
Read moreBitget ajoute les contrats à terme perpétuels sur indices d’actions LLY, MA et UNH alors que le volume cumulé des transactions sur Bitget atteint 3 milliards de dollars
11/14 01:54 am
GlobeNewswire Inc.
Read moreBitget menyenaraikan Niaga Hadapan Kekal Indeks Saham LLY, MA dan UNH apabila jumlah dagangan kumulatif mencecah USD 3 bilion
11/14 01:54 am
GlobeNewswire Inc.
Read moreBitget, 누적 거래량 30억 달러 돌파… LLY·MA·UNH 주식 지수 무기한 선물 신규 상장
11/14 01:54 am
GlobeNewswire Inc.
Read moreBitget lista contratos perpétuos de índices acionários de LLY, MA e UNH à medida que o volume acumulado de trading na plataforma atinge US$ 3 bilhões
11/14 01:54 am
GlobeNewswire Inc.
Read moreビットゲット (Bitget)、LLY、MA、UNH株価指数無期限先物を上場、ビットゲットの累計取引高は30億ドル (約4,639億9,190万円) に到達
11/14 01:54 am
GlobeNewswire Inc.
Read moreBitget רושמת למסחר חוזים מתמשכים על מדדי המניות LLY, MA ו-UNH כאשר נפח המסחר המצטבר ב-Bitget מגיע ל-3 מיליארד דולר
11/14 01:54 am
GlobeNewswire Inc.
Read moreBitget 上線 LLY、MA、UNH 股票指數永續期貨,平台累計交易量突破 30 億美元
11/14 01:54 am
GlobeNewswire Inc.
Read moreBitget 上线 LLY、MA、UNH 股票指数永续合约,平台累计交易额突破 30 亿美元
11/14 01:54 am
GlobeNewswire Inc.
Read moreMangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs
11/13 08:37 pm
GlobeNewswire Inc.
Read moreGate Bioscience Announces $65 Million Oversubscribed Series B Financing to Advance Oral Molecular Gate Medicines into the Clinic
11/13 09:00 am
GlobeNewswire Inc.
Read moreHere Are the Top Growth Healthcare Stocks Every New Investor Should Know
11/13 06:15 am
The Motley Fool
Read more1 Incredible Reason to Buy LLY's Stock in November
11/13 05:25 am
The Motley Fool
Read moreKRAS Inhibitors Market to Witness Explosive Growth at a CAGR of 35% During the Forecast Period (2025–2034) Amid Expanding Therapeutic Landscape | DelveInsight
11/12 02:00 pm
GlobeNewswire Inc.
Read moreDow Jones Hits Record Highs, AMD Jumps: What's Moving Markets Wednesday?
11/12 01:48 pm
Benzinga
Read moreWho's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?
11/11 05:25 am
The Motley Fool
Read moreNovo Nordisk Gains as Strategic Exit From Metsera Deal Restores Investor Trust
11/10 01:41 pm
Investing.com
Read moreEli Lilly Expands Genetic Eye-Disease Focused Pipeline With MeiraGTx Gene Therapy Collaboration
11/10 10:11 am
Benzinga
Read moreHuge News for Eli Lilly Stock and Novo Nordisk Stock Investors as Companies Make Deal With Trump
11/09 06:31 am
The Motley Fool
Read moreThinkCareBelieve: Week 42 of America's Climb into the Golden Age
11/08 11:05 pm
GlobeNewswire Inc.
Read moreEli Lilly's Investigational Obesity Drug Shows Up To 20% Weight Loss In Phase 2 Study, Analyst Sees It As Emerging Cornerstone In Obesity Treatment
11/07 01:33 pm
Benzinga
Read moreEli Lilly Crushed Novo In Obesity Drug Battle—Trump Now Forces Price Cuts
11/06 06:12 pm
Benzinga
Read moreDenali Therapeutics Announces Board and Executive Leadership Updates
11/06 05:00 pm
GlobeNewswire Inc.
Read moreEli Lilly, Novo Nordisk Make Weight-Loss Drugs More Affordable Via Medicare, Medicaid, TrumpRx
11/06 03:10 pm
Benzinga
Read moreNovo Nordisk Has Downgraded Its Outlook for the Fourth Time This Year. Here's What Investors Need to Know.
11/06 02:18 pm
The Motley Fool
Read more3 Early Q3 Earnings Winners Setting the Tone for the Season Ahead
11/06 01:12 pm
Investing.com
Read moreMy 6 Top-Ranked Stocks to Buy Right Now in November
11/06 10:30 am
The Motley Fool
Read more2 Reasons I'm Keeping My Eye on Eli Lilly Stock Right Now
11/05 07:09 pm
The Motley Fool
Read more